首页 > 最新文献

Acta medica academica最新文献

英文 中文
Factors Predictive of In-Hospital Mortality in Patients with Systemic Lupus Erythematosus: A Single-Centre Retrospective Analysis. 预测系统性红斑狼疮患者住院死亡率的因素:单中心回顾性分析
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.400
Sujin Lertwises, Attapon Rattanasupar, Arunchai Chang

Objective: We aimed to investigate the causes and factors predictive of in-hospital death among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care hospital in Thailand.

Materials and methods: We retrospectively reviewed the records of patients with SLE admitted between 2017 and 2021. We collected data related to age, sex, body mass index, comorbidities, disease duration, medication usage, clinical symptoms, vital signs, laboratory results, evidence of infection, presence of systemic inflammatory response syndrome, quick sepsis-related organ assessment scores, and SLE disease activity on the date of admission. The length of hospitalization, treatment administered, and subsequent clinical outcomes (including in-hospital complications and death) were also recorded.

Results: Among 267 enrolled patients, the overall in-hospital mortality rate was 25.5%, and infection was the most common cause of death (75.0%). Multivariate analysis revealed that prior hospitalization within 3 months (odds ratio [OR]: 2.311; 95% confidence interval [CI]: 1.002-5.369; P=0.049), initial infection on admission (OR: 2.764; 95% CI: 1.006-7.594; P=0.048), use of vasopressor drugs (OR: 2.940; 95% CI: 1.071-8.069; P=0.036), and mechanical ventilation (OR: 5.658; 95% CI: 2.046-15.647; P=0.001) were independent risk factors for in-hospital mortality.

Conclusion: Infection was the major cause of mortality in patients with SLE. Prior hospitalization within 3 months, initial infection on admission, vasopressor use, and mechanical ventilation during admission are independent risk factors for in-hospital mortality in patients with SLE.

目的:研究泰国一家三级医院系统性红斑狼疮(SLE)患者住院死亡的原因和预测因素。材料和方法:我们回顾性回顾了2017年至2021年间入院的SLE患者的记录。我们收集了与年龄、性别、体重指数、合并症、病程、药物使用、临床症状、生命体征、实验室结果、感染证据、系统性炎症反应综合征的存在、败血症相关器官快速评估评分和入院时SLE疾病活动性相关的数据。住院时间、接受的治疗以及随后的临床结果(包括院内并发症和死亡)也被记录下来。结果:267例入组患者的住院总死亡率为25.5%,感染是最常见的死亡原因(75.0%)。多因素分析显示,3个月内曾住院(优势比[OR]: 2.311;95%置信区间[CI]: 1.002-5.369;P=0.049),入院时初次感染(OR: 2.764;95% ci: 1.006-7.594;P=0.048)、血管加压药物的使用(OR: 2.940;95% ci: 1.071-8.069;P=0.036),机械通气(OR: 5.658;95% ci: 2.046-15.647;P=0.001)是院内死亡率的独立危险因素。结论:感染是SLE患者死亡的主要原因。3个月内住院史、入院时初次感染、使用血管加压药、入院时机械通气是SLE患者院内死亡的独立危险因素。
{"title":"Factors Predictive of In-Hospital Mortality in Patients with Systemic Lupus Erythematosus: A Single-Centre Retrospective Analysis.","authors":"Sujin Lertwises,&nbsp;Attapon Rattanasupar,&nbsp;Arunchai Chang","doi":"10.5644/ama2006-124.400","DOIUrl":"https://doi.org/10.5644/ama2006-124.400","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to investigate the causes and factors predictive of in-hospital death among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care hospital in Thailand.</p><p><strong>Materials and methods: </strong>We retrospectively reviewed the records of patients with SLE admitted between 2017 and 2021. We collected data related to age, sex, body mass index, comorbidities, disease duration, medication usage, clinical symptoms, vital signs, laboratory results, evidence of infection, presence of systemic inflammatory response syndrome, quick sepsis-related organ assessment scores, and SLE disease activity on the date of admission. The length of hospitalization, treatment administered, and subsequent clinical outcomes (including in-hospital complications and death) were also recorded.</p><p><strong>Results: </strong>Among 267 enrolled patients, the overall in-hospital mortality rate was 25.5%, and infection was the most common cause of death (75.0%). Multivariate analysis revealed that prior hospitalization within 3 months (odds ratio [OR]: 2.311; 95% confidence interval [CI]: 1.002-5.369; P=0.049), initial infection on admission (OR: 2.764; 95% CI: 1.006-7.594; P=0.048), use of vasopressor drugs (OR: 2.940; 95% CI: 1.071-8.069; P=0.036), and mechanical ventilation (OR: 5.658; 95% CI: 2.046-15.647; P=0.001) were independent risk factors for in-hospital mortality.</p><p><strong>Conclusion: </strong>Infection was the major cause of mortality in patients with SLE. Prior hospitalization within 3 months, initial infection on admission, vasopressor use, and mechanical ventilation during admission are independent risk factors for in-hospital mortality in patients with SLE.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"37-46"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b8/19/AMA-52-37.PMC10316072.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Coexistence of an Incomplete Superficial Palmar Arch and a Berrettini Anastomosis: A Case Report. 掌浅弓不全与Berrettini吻合并存1例。
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.401
Ioannis Antonopoulos, Panagiotis Giavopoulos, Dimosthenis Chrysikos, Dimitrios Filippou, Theodore Troupis

Objective: The aim of this study is to present a relatively rare case of the coexistence of an incomplete superficial palmar arch and a Berrettini anastomosis, identified in a cadaveric specimen, and further discuss the potential clinical implications of such anatomical variations.

Case report: The variation was found in the left hand of a formalin-fixed male cadaver of Greek origin, that was dissected under an operating microscope (×4, ×10 magnification) in our Anatomy Department. In the specimen, we found an incomplete superficial palmar arch, formed only by the superficial branch of the ulnar artery, and a Type 1 Berrettini Anastomosis, originating from the ulnar nerve and joining a branch of the median nerve.

Conclusion: To avoid iatrogenic damage and permanent loss of sensation, hand surgeons and microsurgeons should be aware of the presence of a BA, and the potential coexistence of this variation with vascular abnormalities in the hand that may complicate surgical procedures.

目的:本研究的目的是报道一个相对罕见的在尸体标本中发现的不完整掌浅弓和Berrettini吻合并存的病例,并进一步讨论这种解剖变异的潜在临床意义。病例报告:在解剖科手术显微镜(×4, ×10放大)下解剖的一具希腊裔福尔马林固定男性尸体的左手发现变异。在标本中,我们发现一个不完整的掌浅弓,仅由尺动脉浅支形成,以及一个1型Berrettini吻合,起源于尺神经并与正中神经的一个分支相连。结论:为了避免医源性损伤和永久性感觉丧失,手外科医生和显微外科医生应该意识到BA的存在,以及这种变异与手部血管异常的潜在共存,这可能会使手术复杂化。
{"title":"The Coexistence of an Incomplete Superficial Palmar Arch and a Berrettini Anastomosis: A Case Report.","authors":"Ioannis Antonopoulos,&nbsp;Panagiotis Giavopoulos,&nbsp;Dimosthenis Chrysikos,&nbsp;Dimitrios Filippou,&nbsp;Theodore Troupis","doi":"10.5644/ama2006-124.401","DOIUrl":"https://doi.org/10.5644/ama2006-124.401","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study is to present a relatively rare case of the coexistence of an incomplete superficial palmar arch and a Berrettini anastomosis, identified in a cadaveric specimen, and further discuss the potential clinical implications of such anatomical variations.</p><p><strong>Case report: </strong>The variation was found in the left hand of a formalin-fixed male cadaver of Greek origin, that was dissected under an operating microscope (×4, ×10 magnification) in our Anatomy Department. In the specimen, we found an incomplete superficial palmar arch, formed only by the superficial branch of the ulnar artery, and a Type 1 Berrettini Anastomosis, originating from the ulnar nerve and joining a branch of the median nerve.</p><p><strong>Conclusion: </strong>To avoid iatrogenic damage and permanent loss of sensation, hand surgeons and microsurgeons should be aware of the presence of a BA, and the potential coexistence of this variation with vascular abnormalities in the hand that may complicate surgical procedures.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"47-50"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9f/46/AMA-52-47.PMC10316074.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9740836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When to Attend a Webinar? 什么时候参加网络研讨会?
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.404
Farrokh Habibzadeh

Objective: To determine the most appropriate delay to start a webinar.

Methods: This cross-sectional study was conducted on weekly general staff scientific webinars held by the Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore, USA. 35 observations were made at arbitrary chosen times of three consecutive IHV webinars. After standardizing the number of participants, a 4th-degree polynomial fit was applied to the data. A cost function was defined as the sum of the time wasted for those who attended the webinar early and the lost for those who attend with delay. The cost function was minimized to compute the most appropriate delay to start the webinar.

Results: The model could explain almost 95% of the observed variance in the number of participants. Normally, half of the participants attended the meeting at the webinar set starting time. The cost was a minimum if the webinar was delayed for about 3 minutes.

Conclusion: It seems that the most appropriate time for starting the IHV general staff meetings is around 3 minutes after the webinar set starting time.

目的:确定网络研讨会最合适的开始时间。方法:本横断面研究是在美国巴尔的摩马里兰大学医学院人类病毒学研究所(IHV)每周一次的普通员工科学网络研讨会上进行的。在三个连续的IHV网络研讨会的任意选择时间进行了35次观察。标准化参与者数量后,对数据进行四次多项式拟合。成本函数定义为提前参加会议的人所浪费的时间和延迟参加会议的人所损失的时间之和。最小化成本函数以计算最合适的网络研讨会开始延迟。结果:该模型可以解释几乎95%的观察到的参与者数量的方差。通常情况下,一半的参与者在网络研讨会设定的开始时间参加会议。如果网络研讨会延迟约3分钟,成本是最低的。结论:IHV全体工作人员会议的最佳开始时间似乎是在网络研讨会设定的开始时间后3分钟左右。
{"title":"When to Attend a Webinar?","authors":"Farrokh Habibzadeh","doi":"10.5644/ama2006-124.404","DOIUrl":"https://doi.org/10.5644/ama2006-124.404","url":null,"abstract":"<p><strong>Objective: </strong>To determine the most appropriate delay to start a webinar.</p><p><strong>Methods: </strong>This cross-sectional study was conducted on weekly general staff scientific webinars held by the Institute of Human Virology (IHV), University of Maryland School of Medicine, Baltimore, USA. 35 observations were made at arbitrary chosen times of three consecutive IHV webinars. After standardizing the number of participants, a 4th-degree polynomial fit was applied to the data. A cost function was defined as the sum of the time wasted for those who attended the webinar early and the lost for those who attend with delay. The cost function was minimized to compute the most appropriate delay to start the webinar.</p><p><strong>Results: </strong>The model could explain almost 95% of the observed variance in the number of participants. Normally, half of the participants attended the meeting at the webinar set starting time. The cost was a minimum if the webinar was delayed for about 3 minutes.</p><p><strong>Conclusion: </strong>It seems that the most appropriate time for starting the IHV general staff meetings is around 3 minutes after the webinar set starting time.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"63-66"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/7d/AMA-52-63.PMC10316075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Brachiocephalic Trunk Variant Origin and High-Riding Course: Two Cadaveric Cases. 头臂躯干变异起源与高程:两例尸体。
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.402
George Tsakotos, Theano Demesticha, Vasilios Karampelias, Konstantinos Natsis, Vasilios Protogerou, Dimitrios Schizas, Ilenia Chatziandreou, Georgia Kostare, Maria Piagkou

Objective: The current report describes two rare cadaveric findings of a left sided brachiocephalic trunk (BCT) in relation to the trachea, and its high-riding course above the suprasternal notch (SN).

Cases description: In two elderly body donors dissected after death, a left-sided BCT was identified with a high-riding course (0.5 and 0.8 cm above the SN). The BCT originated from the aortic arch, in common with the left common carotid artery, more distally than the typical left-side location and crossed in front of the trachea. In the 1st case, the ascending and descending aortae, and the left subclavian artery had aneurysmal dilatation. In both cases, the trachea was displaced to the right side and had a stenosis due to the chronic compression.

Conclusion: A high-riding BCT is of paramount clinical importance, as it may complicate tracheotomy, thyroid surgery and mediastinoscopy, leading to fatal complications. BCT injury leads to a massive bleeding during neck dissection (level VI), when the vessel crosses the anterior tracheal wall.

目的:本报告描述了两个罕见的尸体发现左侧头臂干(BCT)与气管的关系,以及它在胸骨上切迹(SN)上方的高程。病例描述:在两例死后解剖的老年供体中,发现左侧BCT呈高骑程(SN上方0.5和0.8 cm)。BCT起源于主动脉弓,与左侧颈总动脉共同,比典型的左侧位置更远,并在气管前方交叉。1例升、降主动脉及左锁骨下动脉动脉瘤样扩张。在这两种情况下,气管移位到右侧,并有狭窄,由于慢性压迫。结论:高位BCT具有重要的临床意义,因为它可能导致气管切开术、甲状腺手术和纵隔镜检查的并发症,导致致命的并发症。当血管穿过气管前壁时,BCT损伤导致颈部剥离(VI级)时大量出血。
{"title":"The Brachiocephalic Trunk Variant Origin and High-Riding Course: Two Cadaveric Cases.","authors":"George Tsakotos,&nbsp;Theano Demesticha,&nbsp;Vasilios Karampelias,&nbsp;Konstantinos Natsis,&nbsp;Vasilios Protogerou,&nbsp;Dimitrios Schizas,&nbsp;Ilenia Chatziandreou,&nbsp;Georgia Kostare,&nbsp;Maria Piagkou","doi":"10.5644/ama2006-124.402","DOIUrl":"https://doi.org/10.5644/ama2006-124.402","url":null,"abstract":"<p><strong>Objective: </strong>The current report describes two rare cadaveric findings of a left sided brachiocephalic trunk (BCT) in relation to the trachea, and its high-riding course above the suprasternal notch (SN).</p><p><strong>Cases description: </strong>In two elderly body donors dissected after death, a left-sided BCT was identified with a high-riding course (0.5 and 0.8 cm above the SN). The BCT originated from the aortic arch, in common with the left common carotid artery, more distally than the typical left-side location and crossed in front of the trachea. In the 1st case, the ascending and descending aortae, and the left subclavian artery had aneurysmal dilatation. In both cases, the trachea was displaced to the right side and had a stenosis due to the chronic compression.</p><p><strong>Conclusion: </strong>A high-riding BCT is of paramount clinical importance, as it may complicate tracheotomy, thyroid surgery and mediastinoscopy, leading to fatal complications. BCT injury leads to a massive bleeding during neck dissection (level VI), when the vessel crosses the anterior tracheal wall.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"51-55"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/8c/AMA-52-51.PMC10316069.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation. 骨髓富集队列血液恶性肿瘤患者的SARS-CoV-2疫苗IgG抗体反应:单中心观察
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.399
Fieke W Hoff, Suleyman Y Goksu, Naveen Premnath, Prapti A Patel, Ruth Ikpefan, Gurbakhash Kaur, Madhuri Vusirikala, Taha Bat, Weina Chen, Praveen Ramakrishnan Geethakumari, Larry D Anderson, Farrukh T Awan, Robert H Collins, Olga K Weinberg, Alagarraju Muthukumar, Stephen S Chung, Yazan F Madanat

Objective: Patients diagnosed with hematologic malignancies are at increased risk for severe SARS-CoV-2 infection. We evaluated the serological IgG response following two doses of the SARS-CoV-2 vaccine in patients with hematologic malignancies.

Methods: Patients treated at UT Southwestern Medical Center with a diagnosis of a myeloid or lymphoid neoplasm were included. SARS-CoV-2 vaccination response was defined as a positive quantifiable spike IgG antibody titer.

Results: Sixty patients were included in the study and 60% were diagnosed with a myeloid neoplasm. The majority (85%) of the patients with a myeloid malignancy and 50% of the patients with a lymphoid malignancy mounted a serological response after receiving two doses of the vaccine.

Conclusion: Vaccination should be offered irrespective of ongoing treatment or active disease. Findings require validation in a larger cohort of patients.

目的:诊断为血液系统恶性肿瘤的患者发生严重SARS-CoV-2感染的风险增加。我们评估了血液系统恶性肿瘤患者接种两剂SARS-CoV-2疫苗后血清IgG反应。方法:在德克萨斯大学西南医学中心诊断为髓系或淋巴系肿瘤的患者纳入研究。SARS-CoV-2疫苗接种应答定义为可量化的刺突IgG抗体滴度阳性。结果:60例患者被纳入研究,其中60%被诊断为髓系肿瘤。大多数(85%)髓系恶性肿瘤患者和50%淋巴系恶性肿瘤患者在接种两剂疫苗后出现血清学应答。结论:无论正在进行的治疗或活动性疾病,都应提供疫苗接种。研究结果需要在更大的患者队列中进行验证。
{"title":"SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation.","authors":"Fieke W Hoff,&nbsp;Suleyman Y Goksu,&nbsp;Naveen Premnath,&nbsp;Prapti A Patel,&nbsp;Ruth Ikpefan,&nbsp;Gurbakhash Kaur,&nbsp;Madhuri Vusirikala,&nbsp;Taha Bat,&nbsp;Weina Chen,&nbsp;Praveen Ramakrishnan Geethakumari,&nbsp;Larry D Anderson,&nbsp;Farrukh T Awan,&nbsp;Robert H Collins,&nbsp;Olga K Weinberg,&nbsp;Alagarraju Muthukumar,&nbsp;Stephen S Chung,&nbsp;Yazan F Madanat","doi":"10.5644/ama2006-124.399","DOIUrl":"https://doi.org/10.5644/ama2006-124.399","url":null,"abstract":"<p><strong>Objective: </strong>Patients diagnosed with hematologic malignancies are at increased risk for severe SARS-CoV-2 infection. We evaluated the serological IgG response following two doses of the SARS-CoV-2 vaccine in patients with hematologic malignancies.</p><p><strong>Methods: </strong>Patients treated at UT Southwestern Medical Center with a diagnosis of a myeloid or lymphoid neoplasm were included. SARS-CoV-2 vaccination response was defined as a positive quantifiable spike IgG antibody titer.</p><p><strong>Results: </strong>Sixty patients were included in the study and 60% were diagnosed with a myeloid neoplasm. The majority (85%) of the patients with a myeloid malignancy and 50% of the patients with a lymphoid malignancy mounted a serological response after receiving two doses of the vaccine.</p><p><strong>Conclusion: </strong>Vaccination should be offered irrespective of ongoing treatment or active disease. Findings require validation in a larger cohort of patients.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"30-36"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/2b/AMA-52-30.PMC10316070.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma. 基于P53/MDM2复合物的结肠癌靶向治疗策略
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.398
Athanasios Niotis, Evangelos Tsiambas, Dimitrios Dimitroulis, Helen Sarlanis, Evangelos Falidas, Nikolaos Kavantzas, Constantinos A Constantinides

In the current molecular review, we describe the mechanisms of TP53/MDM2 deregulation and their impact on the colon adenocarcinoma molecular substrate and phenotype. Among the genes that are critically altered in carcinogenesis, the TP53 tumor suppressor gene is of major importance. The TP53 gene (gene locus: 17p13.1) regulates the cell cycle by controlling the G1/S and G2/M checkpoints securing the normal sequence of cell cycle phases. Furthermore, it is involved in apoptosis programmed cell death. The gene is mutated or epigenetically altered in all epithelial malignancies, including colon adenocarcinoma. Additionally, Mouse Double Minute 2 Homolog (MDM2), a proto-oncogene (12q14.3), acts as a major negative regulator for p53 expression in the p53-MDM2 auto-regulatory pathway. MDM2 binds directly to p53 and represses its transcriptional activity, promoting p53 degradation. CONCLUSION: In colon adenocarcinoma, MDM2 oncogene overexpression directly influences p53 oncoprotein expression levels.

在当前的分子综述中,我们描述了TP53/MDM2失调的机制及其对结肠腺癌分子底物和表型的影响。在癌变过程中发生严重改变的基因中,肿瘤抑制基因TP53具有重要意义。TP53基因(基因座:17p13.1)通过控制G1/S和G2/M检查点来调节细胞周期,确保细胞周期的正常序列。此外,它还参与凋亡程序性细胞死亡。该基因在所有上皮恶性肿瘤中发生突变或表观遗传改变,包括结肠腺癌。此外,小鼠双分钟2同源基因(Mouse Double Minute 2 Homolog, MDM2)是一种原癌基因(12q14.3),在p53-MDM2自调节通路中作为p53表达的主要负调控因子。MDM2直接与p53结合并抑制其转录活性,促进p53降解。结论:在结肠腺癌中,MDM2癌基因过表达直接影响p53癌蛋白表达水平。
{"title":"P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma.","authors":"Athanasios Niotis,&nbsp;Evangelos Tsiambas,&nbsp;Dimitrios Dimitroulis,&nbsp;Helen Sarlanis,&nbsp;Evangelos Falidas,&nbsp;Nikolaos Kavantzas,&nbsp;Constantinos A Constantinides","doi":"10.5644/ama2006-124.398","DOIUrl":"https://doi.org/10.5644/ama2006-124.398","url":null,"abstract":"<p><p>In the current molecular review, we describe the mechanisms of TP53/MDM2 deregulation and their impact on the colon adenocarcinoma molecular substrate and phenotype. Among the genes that are critically altered in carcinogenesis, the TP53 tumor suppressor gene is of major importance. The TP53 gene (gene locus: 17p13.1) regulates the cell cycle by controlling the G1/S and G2/M checkpoints securing the normal sequence of cell cycle phases. Furthermore, it is involved in apoptosis programmed cell death. The gene is mutated or epigenetically altered in all epithelial malignancies, including colon adenocarcinoma. Additionally, Mouse Double Minute 2 Homolog (MDM2), a proto-oncogene (12q14.3), acts as a major negative regulator for p53 expression in the p53-MDM2 auto-regulatory pathway. MDM2 binds directly to p53 and represses its transcriptional activity, promoting p53 degradation. CONCLUSION: In colon adenocarcinoma, MDM2 oncogene overexpression directly influences p53 oncoprotein expression levels.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"24-29"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/8f/AMA-52-24.PMC10316079.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Knowledge and Attitudes regarding Covid-19 Vaccination among Medical and Non-medical Students in Bosnia and Herzegovina. 波斯尼亚和黑塞哥维那医科和非医科学生对Covid-19疫苗接种的知识和态度
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.396
Adaleta Softić, Elma Omeragić, Martin Kondža, Nahida Srabović, Aida Smajlović, Esmeralda Dautović, Nataša Bubić Pajić, Tamer Bego, Žarko Gagić, Ivica Brizić, Anđelka Račić, Ervina Bečić, Belma Pehlivanović, Šejla Šabić, Edin Suljagić, Adnan Hukić, Daria Pavlić, Andrea Lučić

Objective: The aim of this study was to investigate students' knowledge, attitudes and hesitancy regarding COVID-19 vaccination.

Methods: A cross-sectional questionnaire-based survey was conducted among a total of 1282 medical students and 509 non-medical students at four public universities in Bosnia and Herzegovina: Tuzla, Sarajevo, Banja Luka, and Mostar.

Results: A significantly higher rate of vaccination was observed in the group of medical students as well as a higher level of knowledge about vaccination in general and vaccines against the COVID-19 disease. Students who received the COVID-19 vaccine had a higher level of knowledge about vaccination in general and COVID-19 vaccines in particular compared to the non-vaccinated students in the medical and non-medical groups, respectively. Furthermore, vaccinated students, regardless of the course they are taking, showed generally stronger positive attitudes compared to non-vaccinated students, regarding the safety and effectiveness of the COVID-19 vaccine. Both groups of students believe that the rapid development of the vaccine is contributing to refusal or hesitancy to receive a vaccine against COVID-19. Social media/networks were the main sources of information about the COVID-19 vaccine. We did not find any contribution of social media to the reduced level of COVID-19 vaccine coverage.

Conclusion: Education of students about the benefits of the COVID-19 vaccine will lead to its better acceptance as well as the development of more positive attitudes towards vaccination in general, especially having in mind that students are the future population of parents, who will make decisions about vaccinating their children.

目的:调查学生对新冠肺炎疫苗接种的知识、态度和犹豫。方法:采用横断面问卷调查的方法,对波黑图兹拉、萨拉热窝、巴尼亚卢卡和莫斯塔尔四所公立大学的1282名医学生和509名非医学生进行调查。结果:医学生群体的疫苗接种率明显较高,对预防接种和COVID-19疾病疫苗的知识水平也较高。与未接种疫苗的医疗组和非医疗组学生相比,接种了COVID-19疫苗的学生对疫苗接种的总体知识水平更高,特别是COVID-19疫苗。此外,与未接种疫苗的学生相比,接种疫苗的学生,无论他们参加什么课程,对COVID-19疫苗的安全性和有效性普遍表现出更积极的态度。两组学生都认为,疫苗的快速发展是导致拒绝或犹豫接种COVID-19疫苗的原因。社交媒体/网络是有关COVID-19疫苗的主要信息来源。我们没有发现社交媒体对降低COVID-19疫苗覆盖率有任何贡献。结论:对学生进行关于COVID-19疫苗益处的教育将使其更好地接受,并在总体上对疫苗接种产生更积极的态度,特别是考虑到学生是未来的父母群体,他们将决定是否为子女接种疫苗。
{"title":"Knowledge and Attitudes regarding Covid-19 Vaccination among Medical and Non-medical Students in Bosnia and Herzegovina.","authors":"Adaleta Softić,&nbsp;Elma Omeragić,&nbsp;Martin Kondža,&nbsp;Nahida Srabović,&nbsp;Aida Smajlović,&nbsp;Esmeralda Dautović,&nbsp;Nataša Bubić Pajić,&nbsp;Tamer Bego,&nbsp;Žarko Gagić,&nbsp;Ivica Brizić,&nbsp;Anđelka Račić,&nbsp;Ervina Bečić,&nbsp;Belma Pehlivanović,&nbsp;Šejla Šabić,&nbsp;Edin Suljagić,&nbsp;Adnan Hukić,&nbsp;Daria Pavlić,&nbsp;Andrea Lučić","doi":"10.5644/ama2006-124.396","DOIUrl":"https://doi.org/10.5644/ama2006-124.396","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate students' knowledge, attitudes and hesitancy regarding COVID-19 vaccination.</p><p><strong>Methods: </strong>A cross-sectional questionnaire-based survey was conducted among a total of 1282 medical students and 509 non-medical students at four public universities in Bosnia and Herzegovina: Tuzla, Sarajevo, Banja Luka, and Mostar.</p><p><strong>Results: </strong>A significantly higher rate of vaccination was observed in the group of medical students as well as a higher level of knowledge about vaccination in general and vaccines against the COVID-19 disease. Students who received the COVID-19 vaccine had a higher level of knowledge about vaccination in general and COVID-19 vaccines in particular compared to the non-vaccinated students in the medical and non-medical groups, respectively. Furthermore, vaccinated students, regardless of the course they are taking, showed generally stronger positive attitudes compared to non-vaccinated students, regarding the safety and effectiveness of the COVID-19 vaccine. Both groups of students believe that the rapid development of the vaccine is contributing to refusal or hesitancy to receive a vaccine against COVID-19. Social media/networks were the main sources of information about the COVID-19 vaccine. We did not find any contribution of social media to the reduced level of COVID-19 vaccine coverage.</p><p><strong>Conclusion: </strong>Education of students about the benefits of the COVID-19 vaccine will lead to its better acceptance as well as the development of more positive attitudes towards vaccination in general, especially having in mind that students are the future population of parents, who will make decisions about vaccinating their children.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/d1/AMA-52-1.PMC10316077.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9740838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dr. Isak Samokovlija: Life in a White Coat. Isak Samokovlija博士:白衣人生。
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.406
Jovan Dimitrijević
No abstract available.
{"title":"Dr. Isak Samokovlija: Life in a White Coat.","authors":"Jovan Dimitrijević","doi":"10.5644/ama2006-124.406","DOIUrl":"https://doi.org/10.5644/ama2006-124.406","url":null,"abstract":"No abstract available.","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"73-75"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/44/AMA-52-73.PMC10316068.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Facial Artery as a Branch of the External Carotid Artery in Thomas Turner's (1793-1873) Treatise on the Arterial System (1825) and a Comparison with Modern Anatomy. 托马斯-特纳(1793-1873 年)的《动脉系统论》(1825 年)中作为颈外动脉分支的面动脉以及与现代解剖学的比较。
Q3 Medicine Pub Date : 2023-04-01 DOI: 10.5644/ama2006-124.405
Amir Shihada, Maria Sioula, Panagiotis Georgakopoulos, Evaggelos Mavrommatis

The aim of the present paper is to contribute to the understanding of the history of the anatomical study of the facial artery. The facial artery plays a fundamental role in the study of the anatomy of the face, and in maxillofacial and vascular surgery. The debate on the understating of this vessel is essential in the educational process, with special focus on the historical development of topographical and descriptive ideas about it. The comparison between the study of facial artery in the work of Thomas Turner (1793-1873) and modern anatomical concepts serves as an excellent educational paradigm. The documentary research method was used this short historical survey. CONCLUSION: Thomas Turner laid the scientific foundation for the accurate anatomical study of the facial artery.

本文旨在帮助人们了解面部动脉解剖学研究的历史。面动脉在面部解剖学研究、颌面外科和血管外科中扮演着重要角色。在教育过程中,对这一血管的认识进行讨论是必不可少的,尤其要关注有关它的地形学和描述性观点的历史发展。托马斯-特纳(Thomas Turner,1793-1873 年)作品中对面部动脉的研究与现代解剖学概念之间的比较是一个很好的教育范例。本简短历史调查采用了文献研究法。结论:托马斯-特纳为面部动脉的精确解剖研究奠定了科学基础。
{"title":"The Facial Artery as a Branch of the External Carotid Artery in Thomas Turner's (1793-1873) Treatise on the Arterial System (1825) and a Comparison with Modern Anatomy.","authors":"Amir Shihada, Maria Sioula, Panagiotis Georgakopoulos, Evaggelos Mavrommatis","doi":"10.5644/ama2006-124.405","DOIUrl":"10.5644/ama2006-124.405","url":null,"abstract":"<p><p>The aim of the present paper is to contribute to the understanding of the history of the anatomical study of the facial artery. The facial artery plays a fundamental role in the study of the anatomy of the face, and in maxillofacial and vascular surgery. The debate on the understating of this vessel is essential in the educational process, with special focus on the historical development of topographical and descriptive ideas about it. The comparison between the study of facial artery in the work of Thomas Turner (1793-1873) and modern anatomical concepts serves as an excellent educational paradigm. The documentary research method was used this short historical survey. CONCLUSION: Thomas Turner laid the scientific foundation for the accurate anatomical study of the facial artery.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"52 1","pages":"67-72"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/22/17/AMA-52-67.PMC10316073.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9747395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dr. Maša Živanović: A Pioneer in Health Care for Women and Children in Bosnia and Herzegovina. Maša Živanović博士:波斯尼亚和黑塞哥维那妇女和儿童保健的先驱。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.395
Husref Tahirović, Maša Miloradović, Jelena Jovanović Simić

The aim of the article is to present, primarily to the medical world and also the general public, the personality and work of Maša Živanović (1890-1960), a pioneer in the health care of children and mothers in Bosnia and Herzegovina (BH), a health educator and one of the leaders of the Yugoslav Women's Rights Movement in the period between the two world wars. She was born in Croatia (then part of the Austro-Hungarian Empire) as Maria Skopszyński, in a family of Polish-Czech origin. After studying at the Temporary Women's Lyceum in Zagreb and passing the matriculation exam at the boy's High School (1909), she obtained the title of Doctor of Medicine in Vienna (1916). Her activity in the Women's Rights Movement has so far generally attracted more attention from researchers than her medical work. However, this work was very important because the general and health education of women, expectant mothers and mothers, after the two World Wars was very poor in BH, and the rates of child morbidity and mortality were high. Maša Živanović spent almost her entire working life in Sarajevo. For 30 years, she was the head of the Dispensary for Mothers and the Children, later the Institute for Maternal and Child Health Care, into which the previous institution grew in 1931. She was among the first followers of the new concept of "comprehensive paediatrics", which included social care for children, disease prevention and treatment of the sick. She successfully connected the medical mission with the mission of a women's rights activist, also trying to act as a health educator through articles published in the Women's Movement magazine (Ženski pokret). For a time, she was the president of the Society for the Education of Woman and Protection of her Rights, i.e. the Women's Movement, and a delegate at conferences of international feminist organizations. CONCLUSION: Maša Živanović was a physician, a pioneer in the health care of children and mothers in BH, a long-time director of the Institute for Health Care of Mothers and Children in Sarajevo, and one of the leaders of the Yugoslav Women's Rights Movement.

这篇文章的目的主要是向医学界和一般公众介绍Maša Živanović(1890-1960)的个性和工作,她是波斯尼亚和黑塞哥维那(BH)儿童和母亲保健的先驱、保健教育家和两次世界大战期间南斯拉夫妇女权利运动的领导人之一。她出生在克罗地亚(当时是奥匈帝国的一部分),原名玛丽亚Skopszyński,出生于一个波兰-捷克血统的家庭。在萨格勒布的临时女子学园学习并通过男子高中的入学考试(1909年)后,她获得了维也纳的医学博士头衔(1916年)。迄今为止,她在女权运动中的活动比她的医疗工作更吸引研究人员的关注。然而,这项工作非常重要,因为在两次世界大战之后,波黑妇女、孕妇和母亲的一般教育和健康教育非常差,儿童发病率和死亡率很高。Maša Živanović她几乎整个职业生涯都在萨拉热窝度过。30年来,她一直是母亲和儿童药房的负责人,后来是妇幼保健研究所,前身是1931年发展起来的机构。她是“综合儿科”新概念的首批追随者之一,该概念包括对儿童的社会关怀、疾病预防和病人治疗。她成功地将医疗使命与妇女权利活动家的使命联系起来,并试图通过在《妇女运动》杂志(Ženski pokret)上发表的文章充当卫生教育工作者。有一段时间,她是妇女教育和保护妇女权利协会(即妇女运动)的主席,也是国际女权组织会议的代表。结论:Maša Živanović是一名医生,是波黑妇幼保健领域的先驱,长期担任萨拉热窝妇幼保健研究所所长,也是南斯拉夫妇女权利运动的领导人之一。
{"title":"Dr. Maša Živanović: A Pioneer in Health Care for Women and Children in Bosnia and Herzegovina.","authors":"Husref Tahirović,&nbsp;Maša Miloradović,&nbsp;Jelena Jovanović Simić","doi":"10.5644/ama2006-124.395","DOIUrl":"https://doi.org/10.5644/ama2006-124.395","url":null,"abstract":"<p><p>The aim of the article is to present, primarily to the medical world and also the general public, the personality and work of Maša Živanović (1890-1960), a pioneer in the health care of children and mothers in Bosnia and Herzegovina (BH), a health educator and one of the leaders of the Yugoslav Women's Rights Movement in the period between the two world wars. She was born in Croatia (then part of the Austro-Hungarian Empire) as Maria Skopszyński, in a family of Polish-Czech origin. After studying at the Temporary Women's Lyceum in Zagreb and passing the matriculation exam at the boy's High School (1909), she obtained the title of Doctor of Medicine in Vienna (1916). Her activity in the Women's Rights Movement has so far generally attracted more attention from researchers than her medical work. However, this work was very important because the general and health education of women, expectant mothers and mothers, after the two World Wars was very poor in BH, and the rates of child morbidity and mortality were high. Maša Živanović spent almost her entire working life in Sarajevo. For 30 years, she was the head of the Dispensary for Mothers and the Children, later the Institute for Maternal and Child Health Care, into which the previous institution grew in 1931. She was among the first followers of the new concept of \"comprehensive paediatrics\", which included social care for children, disease prevention and treatment of the sick. She successfully connected the medical mission with the mission of a women's rights activist, also trying to act as a health educator through articles published in the Women's Movement magazine (Ženski pokret). For a time, she was the president of the Society for the Education of Woman and Protection of her Rights, i.e. the Women's Movement, and a delegate at conferences of international feminist organizations. CONCLUSION: Maša Živanović was a physician, a pioneer in the health care of children and mothers in BH, a long-time director of the Institute for Health Care of Mothers and Children in Sarajevo, and one of the leaders of the Yugoslav Women's Rights Movement.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"249-263"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/76/AMA-51-249.PMC10116176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9688950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica academica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1